基于不同STR分型试剂盒的肿瘤组织身源鉴定方法
			 | 
		
		
		| 
		  	
						       		吴黎明, 陈安琪, 张素华, 李成涛
						  	
		 | 
	
			
			
				 
					Identification Methods of Tumor Tissue Origin Based on Different STR Typing Kits
				
			 | 
		
		
		| 
			
						       		Li-ming WU, An-qi CHEN, Su-hua ZHANG, Cheng-tao LI
						  	
		 | 
	
	
		 | 
	
	
		表4 8个试剂盒区分PC组与UI、FS、PO组所需的A2阈值
  | 
	
	
		Tab. 4 The A2 thresholds required for 8 kits to distinguish the PC group from the UI, FS and PO groups
  | 
	
	
		 | 
	
	
		
			| 试剂盒 | 基因座数量/个 | PC vs UI | PC vs FS | PC vs PO | 
|---|
 | A2 | 灵敏度/% | 特异度/% | 约登指数 | A2 | 灵敏度/% | 特异度/% | 约登指数 | A2 | 灵敏度/% | 特异度/% | 约登指数 | 
|---|
 | AmpFℓSTRTM IdentifilerTM | 15 | ≥9 | 100.00 | 96.51 | 96.51 | ≥10 | 100.00 | 96.36 | 96.36 | ≥7 | 100.00 | 98.18 | 98.18 |  | AmpFℓSTRTM SinofilerTM | 15 | ≥9 | 100.00 | 97.26 | 97.26 | ≥11 | 98.18 | 98.18 | 96.36 | ≥8 | 100.00 | 97.27 | 97.27 |  | AGCU EX22 | 21 | ≥11 | 100.00 | 97.58 | 97.58 | ≥13 | 100.00 | 98.18 | 98.18 | ≥10 | 100.00 | 97.27 | 97.27 |  | AmpFℓSTRTM NGM | 15 | ≥10 | 98.18 | 99.58 | 97.76 | ≥9 | 100.00 | 96.36 | 96.36 | ≥8 | 100.00 | 97.27 | 97.27 |  | PowerPlex® 16 | 15 | ≥9 | 100.00 | 98.18 | 98.18 | ≥10 | 98.18 | 96.36 | 94.54 | ≥8 | 100.00 | 97.27 | 97.27 |  | PowerPlex® 21 | 20 | ≥10 | 100.00 | 95.22 | 95.22 | ≥13 | 100.00 | 96.36 | 96.36 | ≥10 | 100.00 | 99.09 | 99.09 |  | Goldeneye® 20A | 19 | ≥10 | 100.00 | 96.46 | 96.46 | ≥13 | 100.00 | 98.18 | 98.18 | ≥10 | 100.00 | 99.09 | 99.09 |  | SiFa-23plex | 21 | ≥11 | 100.00 | 97.38 | 97.38 | ≥13 | 100.00 | 96.36 | 96.36 | ≥10 | 100.00 | 98.18 | 98.18 |   
		 | 
	
	
		 | 
	
	
		 |